← FDA Drug Approvals (Drugs@FDA)
IBRUTINIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2021-03-01
Drug application
- FDA Application #
ANDA211350- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBRUTINIB
- Generic name
- Ibrutinib
- Active ingredients
- IBRUTINIB
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2021-03-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown